• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Silence Therapeutics

edit

Silence Therapeutics is the leading RNAi therapeutics company in Europe. The Company has developed novel, proprietary short interfering RNA (“siRNA”) molecules. These molecules provide a number of advantages over conventional siRNA molecules as they show increased stability against nuclease degradation. In addition, the Company has developed a proprietary systemic delivery system, AtuPLEX. This enables the delivery of siRNA molecules to targeted diseased tissues and cells in the body, whilst increasing their bioavailability and circulation times.

Milestones

edit

• 
  Silence Therapeutics acquired Intradigm Corporation. (12/16/09)
  Posted 1/16/10 at 12:50am via silence-therapeutics.com

Videos

Screenshots

edit

Sources

1. Silence Therapeutics to merge with Intradigm Corp to create leading RNAi therapeutics company (silence-therapeutics.com) [edit]